{"id":"testosterone-cypionate-200mg-3ml","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"drugInteractions":["Anticoagulants","Insulin","Oral hypoglycemics"],"commonSideEffects":[],"contraindications":["Asthma","Benign prostatic hyperplasia","Body fluid retention","Breast Carcinoma in Males","Breast lump","Breastfeeding (mother)","Carcinoma of female breast","Cardiovascular event risk","Cerebrovascular accident","Chloasma","Chorea","Chronic heart failure","Chronic lung disease","Deep venous thrombosis","Dementia","Diabetes mellitus","Disease of liver","Disorder of coronary artery","Disorder of gallbladder","Edema","Endometrial carcinoma","Endometriosis","Epilepsy","Estrogen receptor positive tumor","Family history of malignant neoplasm of breast","Functional visual loss","Gynecomastia","Heart disease","Hepatic porphyria","Humoral hypercalcemia of malignancy","Hypercholesterolemia","Hyperlipoproteinemia","Hypertensive disorder","Hypertensive urgency","Hypertriglyceridemia","Hypocalcemia","Hypothyroidism","Intermenstrual bleeding - irregular","Kidney disease","Malignant tumor of ovary","Mammography abnormal","Migraine","Myocardial infarction","Neoplasm of prostate","Obesity","Pregnancy, function","Pulmonary thromboembolism","Sleep apnea","Smokes tobacco daily","Systemic lupus erythematosus","Thromboembolic disorder","Thrombophilia","Thrombophlebitis","Thrombosis of retinal vein","Uterine leiomyoma"],"specialPopulations":{"Elderly":"Use with caution; increased risk of cardiovascular events","Children":"Use with caution; may affect bone maturation","Pregnant women":"Contraindicated","Nursing mothers":"Contraindicated"}},"trials":[],"_chembl":{"chemblId":"CHEMBL1201101","moleculeType":"Small molecule","molecularWeight":"412.61"},"aliases":[],"patents":[],"pricing":[{"market":"United States","source":"CMS National Average Drug Acquisition Cost (NADAC)","asOfDate":"2024-01-03","unitCost":"$1.3280/GM","priceType":"NADAC","sourceUrl":"https://data.medicaid.gov/dataset/4j6z-xnwq","annualCost":"$485","description":"TESTOSTERONE 1% (25 MG/2.5 G) PK","retrievedDate":"2026-04-07"}],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Testosterone cypionate (200mg/3ml)","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T03:00:11.319589+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T03:00:16.882359+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Testosterone cypionate (200mg/3ml)","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T03:00:17.596466+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Androgen Receptor agonist","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T03:00:19.001367+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201101/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T03:00:18.666687+00:00"}},"offLabel":[],"timeline":[{"date":"N/A","type":"N/A","milestone":"N/A","regulator":"N/A"}],"_dailymed":null,"aiSummary":"Testosterone cypionate is an androgenic steroid used primarily for testosterone replacement therapy in males with hypogonadism. It is a long-acting injectable form of testosterone that helps to restore normal testosterone levels. The drug is not approved by the FDA, which may limit its availability and use in certain regions. Common side effects include acne, increased hair growth, and mood changes. Due to its androgenic properties, it can also lead to more severe side effects such as liver damage and cardiovascular issues. The lack of FDA approval means that its safety and efficacy have not been fully evaluated in the United States.","ecosystem":[],"mechanism":{"target":"Androgen receptor","novelty":"Not novel; a well-established form of testosterone replacement therapy","modality":"Injectable","drugClass":"Androgenic steroid","explanation":"","oneSentence":"","technicalDetail":"The cypionate ester prolongs the half-life of testosterone, allowing for less frequent dosing compared to other forms of testosterone."},"_scrapedAt":"2026-03-28T00:11:48.062Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"commercial":{"yoyGrowth":"N/A","launchDate":"N/A","annualCostUS":"N/A","currentRevenue":"N/A","patientPopulation":"Males with hypogonadism","peakSalesEstimate":"N/A"},"references":[],"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T03:00:20.489935+00:00","fieldsConflicting":2,"overallConfidence":0.8},"biosimilars":[],"competitors":["Testosterone enanthate","Testosterone propionate","Testosterone undecanoate"],"dataSources":[{"url":"https://data.medicaid.gov/dataset/4j6z-xnwq","name":"CMS National Average Drug Acquisition Cost (NADAC)","fields":["pricing"],"retrievedDate":"2026-04-07"},{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Deficiency of testosterone biosynthesis","diseaseId":"deficiency-of-testosterone-biosynthesis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Delayed puberty","diseaseId":"delayed-puberty","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Hormone receptor positive malignant neoplasm of breast","diseaseId":"hormone-receptor-positive-malignant-neoplasm-of-breast","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Klinefelter's syndrome, XXY","diseaseId":"klinefelter's-syndrome-xxy","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"LHRH Deficiency","diseaseId":"lhrh-deficiency","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Male hypogonadism","diseaseId":"male-hypogonadism","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Menopausal flushing","diseaseId":"menopausal-flushing","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Undescended testicle","diseaseId":"undescended-testicle","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":["Hypogonadism","Delayed puberty in males","Breast cancer in postmenopausal women"],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06592144","phase":"PHASE4","title":"TESTO-TRIAL: Use of Testosterone in Critically Ill Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Leticia Maria Defendi Barboza Marson","startDate":"2024-09-09","conditions":"Weaning Failure, Muscle Weakness, Mechanical Ventilation Complication","enrollment":94}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"crossReferences":{"chemblId":"CHEMBL1201101"},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Oncology"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Testosterone cypionate (200mg/3ml)","genericName":"Testosterone cypionate (200mg/3ml)","companyName":"Leticia Maria Defendi Barboza Marson","companyId":"leticia-maria-defendi-barboza-marson","modality":"Small molecule","firstApprovalDate":"N/A","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T03:00:20.489935+00:00","fieldsConflicting":2,"overallConfidence":0.8},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}